Phenacemide: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Phenacemide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{drugbox
{{Drugbox
| verifiedrevid = 408804023
| IUPAC_name = ''N''-carbamoyl-2-phenyl-acetamide
| IUPAC_name = ''N''-carbamoyl-2-phenyl-acetamide
| image = Phenacemide.svg
| image = Phenacemide.png
 
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|CONS|phenacemide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status = 
| routes_of_administration =
 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 22-25 hours.
| excretion =
 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 63-98-9
| CAS_number = 63-98-9
| ATC_prefix = N03
| ATC_prefix = N03
| ATC_suffix = AX07
| ATC_suffix = AX07
| ATC_supplemental =  
| ATC_supplemental =
| PubChem = 4753
| PubChem = 4753
| DrugBank = APRD00089
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| C = 9 | H = 10 | N = 2 | O = 2
| DrugBank = DB01121
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4589
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = PAI7J52V09
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00504
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 918
 
<!--Chemical data-->
| C=9 | H=10 | N=2 | O=2  
| molecular_weight = 178.188 g/mol
| molecular_weight = 178.188 g/mol
| bioavailability =  
| smiles = O=C(NC(=O)N)Cc1ccccc1
| protein_bound =  
| InChI = 1/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13)
| metabolism =  
| InChIKey = XPFRXWCVYUEORT-UHFFFAOYAL
| elimination_half-life = 22-25 hours.
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| excretion =
| StdInChI = 1S/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13)
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| pregnancy_US = <!-- A / B / C / D / X -->
| StdInChIKey = XPFRXWCVYUEORT-UHFFFAOYSA-N
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration =  
}}
}}
                    __NOTOC__
{{SI}}
{{CMG}}
==Overview==
'''Phenacemide''' is an [[anticonvulsant]] of the [[urea]] class.
'''Phenacemide''' is an [[anticonvulsant]] of the [[urea]] class.
==References==
{{Reflist|2}}


==External links==
==External links==
* {{DiseasesDB|34078}}
* {{DiseasesDB|34078}}
* {{MedlinePlusDrugInfo|uspdi|202454}}
* {{MedlinePlusDrugInfo|uspdi|202454}}
* {{cite journal | author = Coker S | title = The use of phenacemide for intractable partial complex epilepsy in children | journal = Pediatr Neurol | volume = 2 | issue = 4 | pages = 230-2 | year = 1986 | id = PMID 3508693}}
* {{cite journal | author = Coker S | title = The use of phenacemide for intractable partial complex epilepsy in children | journal = Pediatr Neurol | volume = 2 | issue = 4 | pages = 230–2 | year = 1986 | pmid = 3508693 | doi = 10.1016/0887-8994(86)90053-6}}
* {{cite journal | author = Coker S, Holmes E, Egel R | title = Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations | journal = Neurology | volume = 37 | issue = 12 | pages = 1861-6 | year = 1987 | id = PMID 3683877}}
* {{cite journal | author = Coker S, Holmes E, Egel R | title = Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations | journal = Neurology | volume = 37 | issue = 12 | pages = 1861–6 | year = 1987 | pmid = 3683877 | doi=10.1212/wnl.37.12.1861}}


{{Anticonvulsants}}
{{Anticonvulsants}}


[[Category:Ureas]]
[[Category:Ureas]]
[[Category:Drug]]


{{anticonvulsant-stub}}
{{anticonvulsant-stub}}

Latest revision as of 13:33, 10 April 2015

Phenacemide
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC code
Pharmacokinetic data
Elimination half-life22-25 hours.
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC9H10N2O2
Molar mass178.188 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Phenacemide

Articles

Most recent articles on Phenacemide

Most cited articles on Phenacemide

Review articles on Phenacemide

Articles on Phenacemide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phenacemide

Images of Phenacemide

Photos of Phenacemide

Podcasts & MP3s on Phenacemide

Videos on Phenacemide

Evidence Based Medicine

Cochrane Collaboration on Phenacemide

Bandolier on Phenacemide

TRIP on Phenacemide

Clinical Trials

Ongoing Trials on Phenacemide at Clinical Trials.gov

Trial results on Phenacemide

Clinical Trials on Phenacemide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phenacemide

NICE Guidance on Phenacemide

NHS PRODIGY Guidance

FDA on Phenacemide

CDC on Phenacemide

Books

Books on Phenacemide

News

Phenacemide in the news

Be alerted to news on Phenacemide

News trends on Phenacemide

Commentary

Blogs on Phenacemide

Definitions

Definitions of Phenacemide

Patient Resources / Community

Patient resources on Phenacemide

Discussion groups on Phenacemide

Patient Handouts on Phenacemide

Directions to Hospitals Treating Phenacemide

Risk calculators and risk factors for Phenacemide

Healthcare Provider Resources

Symptoms of Phenacemide

Causes & Risk Factors for Phenacemide

Diagnostic studies for Phenacemide

Treatment of Phenacemide

Continuing Medical Education (CME)

CME Programs on Phenacemide

International

Phenacemide en Espanol

Phenacemide en Francais

Business

Phenacemide in the Marketplace

Patents on Phenacemide

Experimental / Informatics

List of terms related to Phenacemide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phenacemide is an anticonvulsant of the urea class.

References

External links

  • Template:DiseasesDB
  • Template:MedlinePlusDrugInfo
  • Coker S (1986). "The use of phenacemide for intractable partial complex epilepsy in children". Pediatr Neurol. 2 (4): 230–2. doi:10.1016/0887-8994(86)90053-6. PMID 3508693.
  • Coker S, Holmes E, Egel R (1987). "Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations". Neurology. 37 (12): 1861–6. doi:10.1212/wnl.37.12.1861. PMID 3683877.

Template:Anticonvulsants


Space-filling model of phenobarbital, the most widely-used anticonvulsant in the world  This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://www.wikidoc.org/index.php?title=Phenacemide&oldid=1085779"